Healthcare Stock Surges 158% as Apollo Eyes ₹25,000 Cr HealthCo Listing

Apollo Hospitals Enterprise Limited has confirmed that the demerger process of Apollo HealthCo is progressing, with the company targeting a separate listing by Q4 FY27 and setting an ambitious ₹25,000 crore annual revenue target for the demerged entity.

The healthcare stock has remained in strong focus after delivering a massive 158% return over the last five years, supported by aggressive healthcare expansion, digital health growth, pharmacy business scaling, and strong investor optimism surrounding the Apollo HealthCo demerger story.

The latest update was shared during a recent concall, where the company confirmed that a shareholder meeting related to the demerger process has been scheduled for June 24, 2026.

Apollo HealthCo Demerger Progress

Apollo Hospitals stated that the demerger process is moving ahead as planned, with the company aiming to unlock value through the separate listing of Apollo HealthCo.

Key Demerger Highlights

Parameter	Details
Company	Apollo Hospitals Enterprise Limited
Entity Being Demerged	Apollo HealthCo
Shareholder Meeting Date	June 24, 2026
Target Listing Timeline	Q4 FY27
Revenue Target	₹25,000 Crore
Update Source	Concall Update

The proposed restructuring is expected to provide greater operational focus, financial transparency, and independent growth opportunities for Apollo HealthCo.

Apollo HealthCo Revenue Ambition

Apollo Hospitals has set a bold annual revenue target of ₹25,000 crore for Apollo HealthCo, reflecting the scale at which the company expects the healthcare and pharmacy platform to operate following the demerger.

The target highlights the company’s confidence in growth across:

• Digital Healthcare
• Omni-Channel Pharmacy Business
• Healthcare Technology Platforms
• Diagnostics Expansion
• Consumer Health Ecosystem

Strategic Importance of the Demerger

The Apollo HealthCo demerger is viewed as one of the most significant healthcare restructuring developments in India’s listed healthcare space.

Key Strategic Benefits

Strategic Factor	Expected Impact
Separate Listing	Independent Valuation Unlock
Operational Focus	Improved Business Efficiency
Healthcare Platform Expansion	Faster Growth Scalability
Digital Health Push	Higher Consumer Reach
Revenue Visibility	Long-Term Growth Potential

The move could potentially help Apollo unlock higher shareholder value by separating its healthcare platform and retail-focused operations from the hospital business.

Apollo Hospitals Expands Healthcare Ecosystem

Apollo Hospitals has continued expanding its integrated healthcare ecosystem across:

• Hospitals
• Pharmacies
• Digital Health Platforms
• Diagnostics
• Preventive Healthcare
• Telemedicine Services

The company remains one of India’s largest private healthcare operators with a strong presence across physical healthcare infrastructure and technology-enabled healthcare services.

Healthcare Sector Remains in Focus

India’s healthcare sector continues attracting strong investor attention driven by:

• Rising Healthcare Spending
• Expansion of Digital Health Services
• Growing Insurance Penetration
• Increased Preventive Healthcare Awareness
• Rapid Growth in Pharmacy Platforms

Healthcare companies with integrated ecosystems and digital capabilities are increasingly being viewed as long-term structural growth stories.

Apollo Hospitals Stock Performance

Apollo Hospitals stock has delivered strong long-term returns amid consistent business expansion and improving healthcare demand trends.

Stock Performance Snapshot

Period	Stock Return
1 Day	+2.85%
5 Days	+3.80%
1 Month	+8.51%
6 Months	+11.93%
1 Year	+20.20%
5 Years	+158.03%

The sharp 158% rally over five years reflects strong market confidence in Apollo Hospitals’ long-term healthcare growth strategy and platform expansion opportunities.

Outlook

With Apollo HealthCo’s demerger progressing toward a targeted Q4 FY27 listing and management outlining a ₹25,000 crore revenue ambition, Apollo Hospitals continues positioning itself as a major player in India’s evolving healthcare and digital health ecosystem.

The restructuring could become a major long-term value unlocking trigger for investors as the company scales its healthcare platform business independently.

What is Apollo HealthCo?

Apollo HealthCo is the healthcare and pharmacy-focused business entity of Apollo Hospitals that includes digital healthcare, pharmacy operations, and consumer healthcare services.

What did Apollo Hospitals announce about Apollo HealthCo?

Apollo Hospitals confirmed that the demerger process of Apollo HealthCo is progressing and the company is targeting a separate listing by Q4 FY27.

When is the Apollo HealthCo shareholder meeting scheduled?

The shareholder meeting related to the demerger process is scheduled for June 24, 2026.

What is the revenue target for Apollo HealthCo?

Apollo Hospitals has set an annual revenue target of ₹25,000 crore for Apollo HealthCo.

When is Apollo HealthCo expected to list separately?

The company is targeting a separate listing of Apollo HealthCo in Q4 FY27, subject to regulatory and shareholder approvals.

Why is the Apollo HealthCo demerger important?

The demerger could unlock shareholder value, improve operational focus, and allow independent scaling of Apollo’s healthcare platform and pharmacy business.

How much has Apollo Hospitals stock gained in the last five years?

Apollo Hospitals stock has delivered approximately 158% returns over the last five years.